Windlas Biotech Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015
WINDLAS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Windlas Biotech has informed the stock exchanges that its trading window will be closed from October 1, 2025, until 48 hours after the unaudited financial results for the quarter and half year ended September 30, 2025 are publicly disclosed. This is a routine compliance requirement under SEBI's Insider Trading Regulations, preventing insiders from trading in the company's shares during periods when they may have access to unpublished price-sensitive information. The closure typically begins ahead of the company's Q2 and H1 FY26 results announcement.
This is a standard regulatory filing with no direct impact on shareholders. Insiders, including directors and key employees, are barred from trading in the stock during this period, which is a normal pre-earnings blackout.